ZEVRA THERAPEUTICS, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Zevra Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2024.
  • Zevra Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $911K, a 13.5% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $911K +$108K +13.5% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $1.09M +$188K +20.9% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $790K -$198K -20% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 $698K -$370K -34.6% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $803K -$362K -31.1% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $898K -$192K -17.6% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $988K -$153K -13.4% Dec 31, 2022 10-K 2024-04-01
Q3 2022 $1.07M -$118K -9.95% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $1.17M -$22K -1.85% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $1.09M -$204K -15.8% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $1.14M -$209K -15.5% Dec 31, 2021 10-K 2023-03-07
Q3 2021 $1.19M -$171K -12.6% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $1.19M -$217K -15.5% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 $1.29M -$157K -10.8% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 $1.35M -$187K -12.2% Dec 31, 2020 10-K 2022-03-31
Q3 2020 $1.36M -$292K -17.7% Sep 30, 2020 10-Q 2020-10-30
Q2 2020 $1.4M -$314K -18.3% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 $1.45M -$334K -18.7% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 $1.54M Dec 31, 2019 10-K 2021-03-12
Q3 2019 $1.65M Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $1.72M Jun 30, 2019 10-Q 2019-08-13
Q1 2019 $1.79M Mar 31, 2019 10-Q 2019-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.